Showing 1 - 4 results of 4 for search 'Patricia García Ramírez', query time: 0.03s Refine Results
  1. 1
    Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in a newly diagnosed multiple myeloma

    Isatuximab‐carfilzomib‐dexamethasone immediately after failing of the quadruplet Daratumumab‐bortezomib‐lenalidomide‐dexamethasone (Dara‐VRD): Striking response with no washout in... by Juan José Gil‐Fernández, Patricia García Ramírez, Marta Callejas Charavía

    Published 2024-01-01
    Get full text
    Article
  2. 2
    PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS

    PB2676: ARE NOVEL THERAPEUTIC OPPORTUNITIES LEADING US TO OVERTREAT PATIENTS?: A REVIEW OF END-OF-LIFE SITUATION IN HAEMATOLOGICAL PATIENTS by Celia Martinez Vázquez, Marta Callejas Charavia, Daniel Gainza Miranda, Jose Maria Aspa Cilleruelo, López de Hontanar Guzman, Rodríguez Barquero Pedro Antonio, Paula Gili Herreros, Motornaya Galina, Maria Menor Gómez, Carlota Portocarrero de Las Heras Pérez, Patricia García Ramírez, Garcia Suarez Julio

    Published 2023-08-01
    Get full text
    Article
  3. 3
    Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing

    Novel Candidate <i>loci</i> and Pathogenic Germline Variants Involved in Familial Hematological Malignancies Revealed by Whole-Exome Sequencing by Cristina Andrés-Zayas, Julia Suárez-González, María Chicano-Lavilla, Mariana Bastos Oreiro, Gabriela Rodríguez-Macías, Patricia Font López, Santiago Osorio Prendes, Gillen Oarbeascoa Royuela, Patricia García Ramírez, Rocío Nieves Salgado, Ignacio Gómez-Centurión, Diego Carbonell Muñoz, Paula Muñiz, Mi Kwon, José Luis Díez-Martín, Ismael Buño, Carolina Martínez-Laperche

    Published 2023-02-01
    Get full text
    Article
  4. 4
    COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant

    COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant by Joaquín Martínez-López, Javier de la Cruz, Rodrigo Gil-Manso, Víctor Jiménez Yuste, José María Aspa-Cilleruelo, Cristian Escolano Escobar, Javier López-Jiménez, Rafael Duarte, Cristina Jacome Yerovi, José-Ángel Hernández-Rivas, Regina Herráez, Keina Quiroz-Cervantes, Rosalía Bustelos-Rodriguez, Celina Benavente, Pilar Martínez Barranco, Mariana Bastos Oteiro, Adrián Alegre, Jaime Pérez-Oteyza, Elena Ruiz, Eriel Alexis Marcheco-Pupo, Ángel Cedillo, Teresa de Soto Álvarez, Patricia García Ramirez, Rosalía Alonso Trillo, Pilar Herrera, María Luisa Bengochea Casado, Andrés Arroyo Barea, Jose Manuel Martin De Bustamante, Javier Ortiz, María Calbacho Robles, Julio García-Suárez

    Published 2024-01-01
    Get full text
    Article

Search Tools: